Stayble Therapeutics AB (publ) (STO:STABL)
Sweden
· Delayed Price · Currency is SEK 0.170
-0.004 (-2.07%)
Mar 9, 2026, 12:34 PM CET
Stayble Therapeutics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 2.45 | 2.2 | 14.08 | 12.85 | 37.47 | Upgrade
|
| Cash & Short-Term Investments | 2.45 | 2.2 | 14.08 | 12.85 | 37.47 | Upgrade
|
| Cash Growth | 11.70% | -84.41% | 9.60% | -65.71% | 244.77% | Upgrade
|
| Other Receivables | 0.23 | 0.13 | 0.25 | 0.61 | 0.45 | Upgrade
|
| Receivables | 0.23 | 0.13 | 0.25 | 0.61 | 0.45 | Upgrade
|
| Prepaid Expenses | 0.29 | 1.28 | 1.72 | 0.04 | 0.08 | Upgrade
|
| Total Current Assets | 2.97 | 3.61 | 16.05 | 13.5 | 37.99 | Upgrade
|
| Long-Term Investments | - | - | - | - | 0 | Upgrade
|
| Long-Term Deferred Charges | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | Upgrade
|
| Total Assets | 8.62 | 9.26 | 21.7 | 19.15 | 43.64 | Upgrade
|
| Accounts Payable | 0.23 | 0.27 | 2.55 | 1.04 | 0.43 | Upgrade
|
| Accrued Expenses | 0.36 | 1.07 | 1.56 | 1.82 | 2.2 | Upgrade
|
| Other Current Liabilities | 0.26 | 0.2 | 0.23 | 0.15 | 0.35 | Upgrade
|
| Total Current Liabilities | 0.85 | 1.53 | 4.34 | 3.02 | 2.98 | Upgrade
|
| Long-Term Debt | - | 0.85 | 0.85 | 0.85 | 0.85 | Upgrade
|
| Other Long-Term Liabilities | 0.85 | - | - | - | - | Upgrade
|
| Total Liabilities | 1.7 | 2.38 | 5.19 | 3.87 | 3.83 | Upgrade
|
| Common Stock | 8.37 | 5.68 | 4.12 | 1.8 | 1.8 | Upgrade
|
| Additional Paid-In Capital | - | - | - | 36.08 | 48.18 | Upgrade
|
| Retained Earnings | -3.37 | -0.73 | 10.46 | -24.53 | -12.09 | Upgrade
|
| Comprehensive Income & Other | 1.92 | 1.92 | 1.92 | 1.92 | 1.92 | Upgrade
|
| Shareholders' Equity | 6.92 | 6.87 | 16.51 | 15.28 | 39.81 | Upgrade
|
| Total Liabilities & Equity | 8.62 | 9.26 | 21.7 | 19.15 | 43.64 | Upgrade
|
| Total Debt | - | 0.85 | 0.85 | 0.85 | 0.85 | Upgrade
|
| Net Cash (Debt) | 2.45 | 1.35 | 13.23 | 12 | 36.62 | Upgrade
|
| Net Cash Growth | 82.27% | -89.83% | 10.28% | -67.24% | 272.78% | Upgrade
|
| Net Cash Per Share | 0.04 | 0.04 | 0.51 | 0.87 | 2.64 | Upgrade
|
| Filing Date Shares Outstanding | 64.36 | 51.72 | 31.72 | 13.85 | 13.85 | Upgrade
|
| Total Common Shares Outstanding | 64.36 | 43.72 | 31.72 | 13.85 | 13.85 | Upgrade
|
| Working Capital | 2.12 | 2.07 | 11.71 | 10.48 | 35.01 | Upgrade
|
| Book Value Per Share | 0.11 | 0.16 | 0.52 | 1.10 | 2.87 | Upgrade
|
| Tangible Book Value | 6.92 | 6.87 | 16.51 | 15.28 | 39.81 | Upgrade
|
| Tangible Book Value Per Share | 0.11 | 0.16 | 0.52 | 1.10 | 2.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.